AKSO HEALTH GROUP Stock Price, News & Analysis
Company Description
Akso Health Group (NASDAQ: AHG) is a medical technology and healthcare services company with roots in social e-commerce. The company, formerly known as Xiaobai Maimai Inc., has evolved from operating a social e-commerce platform in China into a business focused on healthcare equipment and product trading, medical devices, and related healthcare services in China and the United States.
According to company disclosures, Akso Health Group operates a social e-commerce platform in China that collaborates with domestic e-commerce platforms and offers users a selection of high-quality and affordable products. Over time, the company began exploring the healthcare equipment and product trading and related healthcare services business, and its revenues have become primarily associated with its medical devices business.
Transition into Healthcare and Medical Devices
The company states that since the end of 2021 it started exploring healthcare equipment and product trading and related healthcare services. It notes that it specializes in the sales of medical devices in China and in the United States. This reflects a strategic shift from a pure e-commerce model toward a healthcare-focused business that combines product sales with service offerings.
In addition, Akso Health Group has described plans to develop a business as a cancer therapy and radiotherapy oncology service provider with operations in the U.S.. The company has outlined intentions related to radiation oncology centers and cancer-related treatment services, indicating an ambition to participate in specialized oncology care.
Online Medical Services and Internet Healthcare
Akso Health Group has expanded into online healthcare through equity interests in medical service providers in China. The company reports that from March 2024 it indirectly acquired equity interests in Tianjin Deyihui Internet Hospital Co., Ltd. and Tianjin Deyihui Clinic Co., Ltd.. These entities provide online medical consultations for initial diagnosis, follow-up consultations, and management of chronic diseases, adding an Internet-based clinical dimension to Akso Health Group’s business.
Earlier, the company announced a plan to make an equity investment in Deyihui, an online clinic based in China, as a way to tap into the online clinic business initially in China. Management described this as part of building a comprehensive medical technology service platform and participating in Internet smart healthcare services.
AI-Powered Healthcare and DeepSeek Integration
Akso Health Group has highlighted its role as an innovative medical technology company in connection with its integration of DeepSeek’s artificial intelligence technology. The company reports that it is using DeepSeek’s multimodal large-scale models, deep learning frameworks, and big data processing capabilities to upgrade its AI-powered diagnosis system.
According to the company, the upgraded system is designed to integrate patient text descriptions, medical imaging, and laboratory test results, using natural language processing and deep learning to provide more accurate diagnoses and personalized treatment recommendations. The company also states that DeepSeek’s model training framework helps refine its AI models, enhancing diagnostic accuracy and response speed.
Akso Health Group further notes that it will utilize DeepSeek to develop an AI-powered medical assistant to support doctors in retrieving patient records, analyzing similar cases, and recommending treatment plans. The company emphasizes human-centric AI interactions intended to create a more natural and empathetic user experience, reduce patient anxiety, and optimize the consultation process.
Radiotherapy Oncology and Cancer Services
In its description of future business directions, Akso Health Group has stated that it plans to develop a new business as a cancer therapy and radiotherapy oncology service provider with operations in the United States. The company has discussed plans related to radiation oncology centers serving cancer patients who require varying stages of treatment, including specialized radiation therapy centers for radiotherapy, personalized consultation, conventional treatment planning, and other cancer-related treatment services.
These statements indicate that Akso Health Group’s healthcare strategy includes both technology-enabled services and physical treatment facilities, particularly in oncology, alongside its medical devices and equipment trading activities.
Stock Listing and Regulatory Context
Akso Health Group’s American depositary shares trade on the Nasdaq Capital Market under the symbol "AHG", as noted in multiple company announcements. The company has disclosed receiving various notifications from Nasdaq regarding minimum bid price requirements, stockholders’ equity requirements, and timely filing requirements for its annual report. These notifications, as described by the company, did not have an immediate effect on the listing or trading of its ADSs at the time of the announcements, and the company indicated its intention to address the deficiencies within the periods provided.
Business Model Overview
Based on the company’s own descriptions, Akso Health Group’s business model combines:
- Social e-commerce in China, collaborating with domestic e-commerce platforms to offer users a selection of products.
- Healthcare equipment and product trading, with a focus on medical devices in China and the United States.
- Radiotherapy oncology and cancer therapy services in the United States, as part of its stated development plans.
- Online medical consultation services in China through equity interests in Internet hospital and clinic entities that handle initial diagnoses, follow-up consultations, and chronic disease management.
- AI-powered medical technology, including AI diagnosis systems and AI medical assistants based on DeepSeek’s technologies.
The company positions these activities as part of a broader effort to build a medical technology service platform that connects devices, clinical services, and intelligent diagnostic tools.
Sector and Industry Classification
Akso Health Group is categorized under the Administrative and Support and Waste Management and Remediation Services sector, within the All Other Business Support Services industry. Within this classification, the company’s disclosures emphasize its focus on healthcare-related services, medical devices, online clinics, and AI-enabled medical technology.
Investor Considerations
For investors researching AHG stock, the company’s own announcements highlight several themes: the evolution from social e-commerce into healthcare; specialization in medical devices in China and the U.S.; ambitions in radiotherapy oncology services; expansion into online medical consultation via equity interests in Internet hospital and clinic entities; and the integration of AI technologies such as DeepSeek to support diagnosis and medical assistance.
Stock Performance
AKSO HEALTH GROUP (AHG) stock last traded at $2.38, down 1.91% from the previous close. Over the past 12 months, the stock has gained 87.3%. At a market capitalization of $2.0B, AHG is classified as a mid-cap stock with approximately 856.7M shares outstanding.
Latest News
AKSO HEALTH GROUP has 7 recent news articles. Of the recent coverage, 1 article coincided with positive price movement and 6 with negative movement. Key topics include AI, acquisition. View all AHG news →
SEC Filings
AKSO HEALTH GROUP has filed 5 recent SEC filings, including 4 Form 3, 1 Form 6-K. The most recent filing was submitted on March 27, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all AHG SEC filings →
Financial Highlights
AKSO HEALTH GROUP generated $14.8M in revenue over the trailing twelve months, retaining a -1.9% gross margin, operating income reached -$166.3M (-1125.4% operating margin), and net income was -$135.0M, reflecting a -913.4% net profit margin. Diluted earnings per share stood at $-0.16. The company generated $1.2M in operating cash flow. With a current ratio of 14.20, the balance sheet reflects a strong liquidity position.
Upcoming Events
Short Interest History
Short interest in AKSO HEALTH GROUP (AHG) currently stands at 18.8 thousand shares, up 28.5% from the previous reporting period, representing 0.0% of the float. Over the past 12 months, short interest has decreased by 57.1%. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for AKSO HEALTH GROUP (AHG) currently stands at 2.5 days, up 149% from the previous period. This days-to-cover ratio represents a balanced liquidity scenario for short positions. The days to cover has decreased 69.5% over the past year, suggesting improved liquidity for short covering. The ratio has shown significant volatility over the period, ranging from 1.0 to 8.2 days.
AHG Company Profile & Sector Positioning
AKSO HEALTH GROUP (AHG) operates in the Medical Distribution industry within the broader Healthcare sector and is listed on the NASDAQ.
Investors comparing AHG often look at related companies in the same sector, including Owens & Minor (OMI), Henry Schein, Inc. (HSIC), Quipt Home Medical Corp (QIPT), 111 (YI), and Inmode Ltd. (INMD). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate AHG's relative position within its industry.